Ketamine as treatment for post-traumatic stress disorder: a review

Felix Liriano, Candace Hatten MD, Thomas L Schwartz MD

Abstract

Post-traumatic stress disorder (PTSD) continues to make headlines given multiple military engagements across the world and civilian traumas, and resultant PTSD development continues at an even pace. Currently, antidepressant and cognitive-behavioral therapy have the greatest evidence base but still do not yield a remission of PTSD symptoms in many patients. Off-label and novel treatments continue to be considered for more refractory and disabling cases of PTSD. Ketamine is one such treatment that has been discussed and utilized more often for treatment-resistant major depressive disorder (MDD). Its mechanism is controversial regarding its potential to create anxiety, but the perceived benefit of a rapid reduction of symptoms makes it worthy for study in animal models of, and possibly human studies in, PTSD. The current literature and theoretical mechanism of action is discussed in this manuscript.

Article Details

Article Type

Review

DOI

10.7573/dic.212305

Publication Dates

Accepted: ; Published: .

Citation

Liriano F, Hatten C, Schwartz TL. Ketamine as treatment for posttraumatic stress disorder: a review. Drugs in Context 2019; 8: 212305. DOI: 10.7573/dic.212305

Article Views

Monthly article views (last 12 months)

Drugs in Context PubMed Central
Source HTML views PDF downloads Totals
Drugs in Context since September 19, 2025 17 4 21
PubMed Central since November 1, 2024 8127 189 8316
Totals 8144 193 8333
Register for alerts

I would like to be contacted by Drugs in Context when new articles are posted.

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.